Log in to your Inderes Free account to see all free content on this page.

Hofseth BioCare

Be the first to follow this company

ShowingAll content types

Regulatory press release12/12/2024, 2:07 PM

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

Hofseth BioCare

Regulatory press release12/5/2024, 8:00 AM

Hofseth Biocare ASA: Commences the project for a second hydrolysis plant in Norway to triple capacity

Hofseth BioCare

Regulatory press release11/8/2024, 11:47 AM

HBC: Financial calendar

Hofseth BioCare

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release11/8/2024, 7:15 AM

Hofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORT

Hofseth BioCare

Regulatory press release10/22/2024, 8:55 AM

Hofseth Biocare ASA: CFO RESIGNATION

Hofseth BioCare

Regulatory press release10/8/2024, 6:45 AM

Hofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENT

Hofseth BioCare

Regulatory press release8/23/2024, 6:00 AM

Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT

Hofseth BioCare

Regulatory press release8/14/2024, 11:09 AM

Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE'S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY

Hofseth BioCare

Regulatory press release8/14/2024, 11:09 AM

Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY

Hofseth BioCare

Regulatory press release7/2/2024, 7:00 AM

Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.

Hofseth BioCare

Regulatory press release7/2/2024, 7:00 AM

Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.

Hofseth BioCare

Regulatory press release6/11/2024, 7:00 AM

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

Hofseth BioCare

Regulatory press release6/11/2024, 7:00 AM

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

Hofseth BioCare

Regulatory press release5/16/2024, 6:00 AM

Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT

Hofseth BioCare

Regulatory press release5/10/2024, 12:30 PM

Hofseth Biocare ASA: Annual General Meeting completed

Hofseth BioCare

Regulatory press release4/19/2024, 11:00 AM

Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024

Hofseth BioCare

Regulatory press release4/19/2024, 6:00 AM

Hofseth Biocare ASA: HBC ANNUAL REPORT 2023

Hofseth BioCare

Regulatory press release4/8/2024, 10:15 AM

HBC: NOTIFICATION OF MAJOR HOLDINGS

Hofseth BioCare

Regulatory press release4/5/2024, 4:08 PM

Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING

Hofseth BioCare

Regulatory press release4/5/2024, 4:08 PM

Hofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDING

Hofseth BioCare

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.